Info
Insider Trading

Insider Transactions Reported by 11 Insiders of ANTARES PHARMA, INC.

Location: Ewing, NJ

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

ANTARES PHARMA, INC. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Thomas J. Garrity	Director				24 May 2022
Anton Gueth	Director				24 May 2022
Robert F. Apple	President and CEO, Director				24 May 2022
Peter J. Graham	EVP, General Counsel, Chief Compliance Officer and Secretary				24 May 2022
Fred M. Powell	Executive Vice President & CFO				24 May 2022
Leonard S. Jacob	Director				24 May 2022
Peter C. Richardson	EVP, Research and Development and Chief Medical Officer				24 May 2022
Robert P. Roche Jr.	Director				24 May 2022
Karen L. Smith	Director				24 May 2022
Peter S. Greenleaf	Director				24 May 2022
Carmen B. Volkart	Director				24 May 2022

Recent Insider Transactions by Companies or Individuals for ANTARES PHARMA, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.